全球粒子束治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

粒子束治療市場預計將從 2025 年的 20.2 億美元成長到 2034 年的 38.8 億美元，2026 年至 2034 年的複合年成長率為 7.5%。

隨著先進癌症治療技術的日益普及，全球粒子束治療市場正蓬勃發展。粒子束治療，包括質子治療和碳離子治療，是一種高精度放射療法，能夠精準靶向癌細胞，同時最大限度地減少對周圍健康組織的損傷。癌症發生率的上升和對先進癌症治療需求的不斷成長是推動市場成長的主要因素。

技術進步和專業癌症治療中心的建立正在加速粒子束療法在全球的普及。各國政府和醫療機構正投資興建先進的放射治療基礎設施，以改善癌症治療效果。此外，持續的臨床研究與開發以及治療計劃系統的改進，也提高了粒子束療法的有效性和可及性。

未來，隨著全球對先進癌症療法的認知度不斷提高，粒子束療法市場預計將持續成長。持續的研發投入、技術創新以及新治療中心的建立將推動市場成長。隨著醫療體系致力於提高癌症存活率和患者生活品質，粒子束療法有望成為現代癌症治療的關鍵組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球粒子束治療市場：依治療類型分類

• 市場分析、洞察與預測
• 質子束療法
• 重離子

第5章 全球粒子束治療市場：依服務類型分類

• 市場分析、洞察與預測
• 迴旋加速器
• 同步輻射
• 同步迴旋加速器

第6章 全球粒子束治療市場：依應用領域分類

• 市場分析、洞察與預測
• 兒童癌症
• 肺癌
• 膀胱癌
• 腦部和脊髓腫瘤（BSCT）
• 乳癌
• 胃腸道癌症
• 肝細胞癌（HCC）
• 頭頸癌（HNC）
• 其他

第7章 全球粒子束治療市場：依最終使用者分類

• 市場分析、洞察與預測
• 醫院
• 學術和研究機構

第8章 全球粒子束治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • HitachiLtd
  • IBA Worldwide
  • Mevion Medical SystemsInc
  • Optivus Proton TherapyInc
  • Protom InternationalInc
  • Provision Healthcare
  • Varian Medical SystemsInc

The Particle Therapy Market size is expected to reach USD 3.88 Billion in 2034 from USD 2.02 Billion (2025) growing at a CAGR of 7.5% during 2026-2034.

The global particle therapy market is gaining momentum as advanced cancer treatment technologies become more widely adopted. Particle therapy, including proton and carbon ion therapy, is a highly precise radiation treatment used to target cancer cells while minimizing damage to surrounding healthy tissues. The growing prevalence of cancer and increasing demand for advanced oncology treatments are key factors driving market growth.

Technological advancements and the development of specialized cancer treatment centers are accelerating the adoption of particle therapy worldwide. Governments and healthcare institutions are investing in advanced radiation therapy infrastructure to improve cancer treatment outcomes. In addition, ongoing clinical research and improved treatment planning systems are enhancing the effectiveness and accessibility of particle therapy.

In the future, the particle therapy market is expected to expand as awareness of advanced cancer treatments increases globally. Continued research, technological innovation, and the establishment of new therapy centers will support market development. As healthcare systems focus on improving cancer survival rates and patient quality of life, particle therapy is likely to become an important component of modern oncology care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy

• Proton Therapy
• Heavy lon

By Services

• Cyclotrons
• Synchrotrons
• Synchrocyclotrons

By Application

• Pediatric Cancer
• Lung Cancer
• Bladder Cancer
• Brain and Spinal Cord Tumors (BSCT)
• Breast Cancer
• Gastrointestinal (GI) Cancers
• Hepatocellular Carcinoma (HCC)
• Head and Neck Cancers (HNC)
• Others

By End-User

• Hospitals
• Academic & Research Centers

COMPANIES PROFILED

• Advanced Oncotherapy PLC, Danfysik AS, Hitachi, Ltd, IBA Worldwide, Mevion Medical Systems, Inc, Optivus Proton Therapy, Inc, Protom International, Inc, Provision Healthcare, Varian Medical Systems, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PARTICLE THERAPY MARKET: BY THERAPY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy
• 4.2. Proton Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Heavy lon Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PARTICLE THERAPY MARKET: BY SERVICES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Services
• 5.2. Cyclotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Synchrotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Synchrocyclotrons Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PARTICLE THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Pediatric Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Bladder Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Brain and Spinal Cord Tumors (BSCT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Gastrointestinal (GI) Cancers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Hepatocellular Carcinoma (HCC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Head and Neck Cancers (HNC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PARTICLE THERAPY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PARTICLE THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Therapy
  • 8.2.2 By Services
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Therapy
  • 8.3.2 By Services
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Therapy
  • 8.4.2 By Services
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Therapy
  • 8.5.2 By Services
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Therapy
  • 8.6.2 By Services
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PARTICLE THERAPY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Advanced Oncotherapy PLC
  • 10.2.2 Danfysik A/S
  • 10.2.3 HitachiLtd
  • 10.2.4 IBA Worldwide
  • 10.2.5 Mevion Medical SystemsInc
  • 10.2.6 Optivus Proton TherapyInc
  • 10.2.7 Protom InternationalInc
  • 10.2.8 Provision Healthcare
  • 10.2.9 Varian Medical SystemsInc